लोड हो रहा है...
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
PURPOSE: Germ cell tumors (GCTs) are cured with therapy based on cisplatin, although a clinically significant number of patients are refractory and die of progressive disease. Based on preclinical studies indicating that refractory testicular GCTs are hypersensitive to hypomethylating agents (HMAs),...
में बचाया:
| में प्रकाशित: | Cancer Med |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley and Sons Inc.
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7826483/ https://ncbi.nlm.nih.gov/pubmed/33135391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3583 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|